Answer given by Mr Kyprianou on behalf of the Commission (8 December 2006) The Commission is trying to develop a Community framework for safe, high quality and efficient health services, by reinforcing cooperation between Member States and providing clarity and certainty over the application of Community law to health services and healthcare COM(2006)122 final. . This is intended to help patients have access to the healthcare they need and to which they are entitled wherever it can best be provided, including in other Member States where that is appropriate. For that purpose, the Commission launched recently a consultation regarding Community action on health services http://ec.europa.eu/health/ph_overview/co_operation/mobility/community_framework_en.htm (for SEC(2006)1195/4 of 26 September 2006). . According to settled case-law of the Court, and as indicated in the recent Commission Communication launching the consultation regarding Community action on health services http://ec.europa.eu/health/ph_overview/co_operation/mobility/community_framework_en.htm (for SEC(2006)1195 of 26 September 2006). , the benefits that different health and social security systems provide and their organisation remain the responsibility of the Member States. This also includes entitlements to medicinal products. Nevertheless, the Member States must comply with Community law when exercising that power. It follows that the competent national or local authorities are free to designate the medicinal products that they wish to include within the scope of their health insurance system, provided that their decisions are made in a transparent manner, in accordance with Council Directive 89/105/EEC of 21 December 1988 Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion within the scope of national health insurance system, OJ L 40, 11.2.1989. , and comply with the rules of the EC Treaty on free movement of goods.